| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.08 |